Self-nanoemulsifying drug delivery systems: Formulation insights, applications and advances

Nanomedicine

Volumn 5, Issue 10, 2010, Pages 1595-1616

  Date, Abhijit A ^a   Desai, Neha ^a   Dixit, Rahul ^a   Nagarsenker, Mangal ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

nanoemulsion; oral delivery; poor bioavailability; self nanoemulsification; SNEDDS; solid SNEDDS

Indexed keywords

ACICLOVIR; ALPHA TOCOPHEROL; AMPHOTERICIN B; ARTEMETHER; ATENOLOL; CALCITONIN; CAMPTOTHECIN; CARBAMAZEPINE; CEFPODOXIME PROXETIL; CELECOXIB; CEPHALOSPORIN; CREMOPHOR; CURCUMIN; CYCLOSPORIN; DIGOXIN; DOXORUBICIN; EZETIMIBE; INSULIN; ITRACONAZOLE; METFORMIN; OLEIC ACID ETHYL ESTER; PACLITAXEL; QUERCETIN; RAMIPRIL; REPAGLINIDE; SAQUINAVIR; SIMVASTATIN; SOYBEAN OIL; UBIDECARENONE; UNINDEXED DRUG;

AQUEOUS SOLUTION; DILUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MEGADOSE; DRUG PENETRATION; DRUG STABILITY; DRUG TRANSPORT; EMULSION; ESTHETICS; FIRST PASS EFFECT; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; MAXIMUM PLASMA CONCENTRATION; NANOEMULSION; NANOFABRICATION; PALATABILITY; PRIORITY JOURNAL; REVIEW; SCALE UP; SOLUBILIZATION; VISCOSITY;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; NANOPARTICLES; NANOTECHNOLOGY;

EID: 78650539714     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.10.126     Document Type: Review

References (114)

1. Boyd BJ: Past and future evolution in colloidal drug delivery systems. Expert Opin. Drug Deliv. 5, 69-85 (2008). (Pubitemid 351234110)
2. Bonacucina G, Cespi M, Misici-Falzi M, Palmieri GF: Colloidal soft matter as drug delivery system. J. Pharm. Sci. 98, 1-42 (2009).
3. Mishra B, Patel BB, Tiwari S: Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine 6, 9-24 (2010).
4. Tadros T, Izquierdo P, Esquena J, Solans C: Formation and stability of nano-emulsions. Adv. Colloid Interface Sci. 108-109, 303-318 (2004).
5. Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ: Nano-emulsions. Curr. Opin. Coll. Int. Sci. 10, 102-110 (2005). (Pubitemid 41565542)
6. Gutirrez JM, Gonzlez C, Maestro A, Sol I, Pey CM, Nolla J: Nano-emulsions: lew applications and optimization of their preparation. Curr. Opin. Coll. Int. Sci. 13, 245-251 (2008). (Pubitemid 351818213)
7. Constantinides PP, Chaubal MV, Shorr R: Advances in lipid nanodispersions for parenteral drug delivery and targeting. Adv. Drug Deliv. Rev. 60, 757-767 (2008).
8. Han M, He CX, Fang QL et al.: A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo. Pharm. Res. 26, 926-935 (2009).
9. Nicolaos G, Crauste-Manciet S, Farinotti R, Brossard D: Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion. Int. J. Pharm. 263, 165-171 (2003). (Pubitemid 37087943)
10. Puglia C, Rizza L, Drechsler M, Bonina F: Nanoemulsions as vehicles for topical administration of glycyrrhetic acid: characterization and in vitro and in vivo evaluation. Drug Deliv. 17(3), 123-129 (2010).
11. Bielinska AU, Janczak KW, Landers JJ et al.: Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge. Infect. Immun. 75, 4020-4029 (2007).
12. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M: Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm. 66, 227-243 (2007). (Pubitemid 46667230)
13. Bali V, Ali M, Ali J: Study of surfactant combinations and development of a novel nanoemulsion for minimizing variations in bioavailability of ezetimibe. Colloids Surf. B Biointerfaces 76, 410-420 (2010).
14. Wang X, Jiang Y, Wang YW, Huang MT, Ho CT, Huang Q: Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chem. 108, 419-424 (2008).
15. Anton N, Benoit JP, Saulnier P: Design and production of nanoparticles formulated from nano-emulsion templates - a review. J. Control. Release 128, 185-199 (2008).
16. Hernndez A, Cano MP: High-pressure and temperature effects on enzyme inactivation in tomato puree. J. Agric. Food. Chem. 46, 266-270 (1998).
17. Tang GQ, Tanaka N, Kunugi S: In vitro increases in plasmid DNA supercoiling by hydrostatic pressure. Biochim. Biophys. Acta 1443, 364-368 (1998). (Pubitemid 29023368)
18. Shinoda K, Saito H: The effect of temperature on the phase equilibria and the types of dispersions of the ternary system composed of water, cyclohexane, and nonionic surfactant. J. Colloid Interface Sci. 26, 70-74 (1968).
19. Shinoda K, Saito H: The stability of o/w type emulsions as a function of temperature and the HLB of emulsifiers: the emulsification by PIT-method. J. Colloid Interface Sci. 30, 258-263 (1969).
20. Izquierdo P, Esquena J, Tadros TF et al.: Phase behavior and nano-emulsion formation by the phase inversion temperature method. Langmuir 20, 6594-6598 (2004).
21. Izquierdo P, Feng J, Esquena J et al.: The influence of surfactant mixing ratio on nano-emulsion formation by the pit method. J. Colloid. Interface. Sci. 285, 388-394 (2005). (Pubitemid 41350451)
22. Fernandez P, Andre V, Rieger J, Kuhnle A: Nano-emulsion formation by emulsion phase inversion. Colloids Surf. A Physicochem. Eng. Asp. 251, 53-58 (2004). (Pubitemid 39574275)
23. Esquena J, Ravi Sankar GSR, Solans C: Highly concentrated W/O emulsions prepared by the PIT method as templates for solid foams. Langmuir 19, 2983-2988 (2003).
24. Peng LC, Liu CH, Kwan CC, Huang KF: Optimization of water-in-oil nanoemulsions by mixed surfactants. Colloids Surf. A Physicochem. Eng. Asp. 370, 136-142 (2010).
25. Anton N, Mojzisova H, Porcher E, Benoit JP, Saulnier P: Reverse micelle-loaded lipid nano-emulsions: new technology for nano-encapsulation of hydrophilic materials. Int. J. Pharm. 398, 204-209 (2010).
26. Bouchemal K, Brianon S, Perrier E, Fessi H: Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation. Int. J. Pharm. 280, 241-251 (2004). (Pubitemid 38960674)
27. Franois G, Katz JL: Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulsification as an alternative to ultrasonic and high-shear devices. Chemphyschem. 6, 209-216 (2005).
28. Kelmann RG, Kuminek G, Teixeira HF, Koester LS: Carbamazepine parenteral nanoemulsions prepared by spontaneous emulsification process. Int. J. Pharm. 342, 231-239 (2007). (Pubitemid 47271896)
29. Forgiarini A, Esquena J, Gonzalez C, Solans C: Formation of nanoemulsions by low-energy emulsification methods at constant temperature. Langmuir 17, 2076-2083 (2001). (Pubitemid 35330144)
30. Sadurn N, Solans C, Azemar N, Garca-Celma MJ: Studies on the formation of O/W nano-emulsions, by low-energy emulsification methods, suitable for pharmaceutical applications. Eur. J. Pharm. Sci. 26, 438-445 (2005). (Pubitemid 41551577)
31. Juan Carlos Lopez-Montilla JC, Herrera-Morales PE, Pandey S, Shah DO: Spontaneous emulsification: mechanisms, physicochemical aspects, modeling, and applications. J. Disp. Sci. Tech. 23, 219-268 (2002). (Pubitemid 34788947)
32. Anton N, Vandamme TF: The universality of low-energy nano-emulsification. Int. J. Pharm. 377, 142-147 (2009).
33. Lipinski C: Poor aqueous solubility-an industry wide problem in drug discovery. Am. Pharm. Rev. 5, 82-85 (2002).
34. Gershanik T, Benita S: Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur. J. Pharm. Biopharm. 50, 179-188 (2000). (Pubitemid 30326696)
35. Aungst B: Intestinal permeation enhancers. J. Pharm. Sci. 89, 429-442 (2000).
36. Patton TF, Gilford P: Effect of various vehicles and vehicle volumes on oral absorption of triamterene in rats. J. Pharm. Sci. 59, 579-589 (1981). (Pubitemid 12175102)
37. Leuner C, Dressman J: Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50, 47-60 (2000). (Pubitemid 30326688)
38. Loftsson T, Brewster ME: Pharmaceutical applications of cyclodextrins. J. Pharm. Sci. 85, 1017-1025 (1996).
39. Bates TR, Carrigan PJ: Apparent absorption kinetics of micronized griseofulvin after its oral administration on single- and multiple-dose regimens to rats as a corn oil-in-water emulsion and aqueous suspension. J. Pharm. Sci. 64, 1475-1481 (1975).
40. Date AA, Nagarsenker MS: Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int. J. Pharm. 329, 166-172 (2007). (Pubitemid 44937527)
41. Gursoy RN, Benita S: Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 58(3), 173-182 (2004). (Pubitemid 38479922)
42. Pouton CW, Porter CJ: Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv. Drug Deliv. Rev. 60(6), 625-637 (2008).
43. Porter CJ, Kaukonen AM, Boyd BJ, Edwards GA, Charman WN: Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation. Pharm. Res. 21, 1405-1412 (2004).
44. Porter CJ, Kaukonen AM, Taillardat-Bertschinger A et al.: Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J. Pharm. Sci. 93, 1110-1121 (2004). (Pubitemid 38529685)
45. Hauss DJ, Fogal SE, Ficorilli, JV et al.: Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J. Pharm. Sci. 87, 164-169 (1998). (Pubitemid 28081323)
46. Lundin P, Bojrup M, Ljusberg-Wahren H, Westrom B, Lundin S: Enhancing effects of monohexanoin and two other medium-chain glyceride vehicles on intestinal absorption of desmopressin (dDAVP). J. Pharm. Exp. Ther. 282, 585-590 (1997). (Pubitemid 27340155)
47. Jumaa M, Müller BW: Formulating and stability of benzodiazepines in a new lipid emulsion formulation. Pharmazie. 57, 740-743 (2002). (Pubitemid 35339950)
48. Basalious EB, Shawky N, Badr-Eldin SM: SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int. J. Pharm. 391, 203-211 (2010).
49. Constantinides PP, Tustian A, Kessler DR: Tocol emulsions for drug solubilization and parenteral delivery. Adv. Drug Deliv. Rev. 56, 1243-1255 (2004). (Pubitemid 38510472)
50. Nepal PR, Han HK, Choi HK: Preparation and in vitro-in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q(10). Eur. J. Pharm. Sci. 39, 224-232 (2010).
51. Strickley RG: Solubilizing excipients in oral and injectable formulations. Pharm. Res. 21, 201-230 (2004).
52. Date AA, Nagarsenker MS: Parenteral microemulsions: an overview. Int. J. Pharm. 355, 19-30 (2008).
53. Dixit RP, Nagarsenker MS: Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev. Ind. Pharm. 34, 1285-1296 (2008).
54. Wang L, Dong J, Chen J, Eastoe J, Li X: Design and optimization of a new self-nanoemulsifying drug delivery system. J. Colloid Interface Sci. 330, 443-448 (2009).
55. Rege BD, Kao J, Pollia J: Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur. J. Pharm. Sci. 16, 237-246 (2002).
56. Mountfield RJ, Senepin S, Schleimer M, Walter I, Bittner B: Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450. Int. J. Pharm. 211, 89-92 (2000). (Pubitemid 32008387)
57. Hugger ED, Novak BL, Burton PS, Audus KL, Borchardt RT: A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit p-glycoprotein activity in vitro. J. Pharm. Sci. 91, 1991-2002 (2002).
58. Tije AJ, Verweij J, Loos WJ et al.: Pharmacological effects of formulation vehicles implications for cancer chemotherapy. Clin. Pharmacokinet. 42, 665-685 (2003). (Pubitemid 36936530)
59. Jumaa M, Müller BW: Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect. Eur. J. Pharm. Sci. 9, 285-290 (2000).
60. Cuine JF, Charman WN, Pouton CW et al.: Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs. Pharm. Res. 24, 748-757 (2007).
61. Cuin JF, McEvoy CL, Charman WN et al.: Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. J. Pharm. Sci. 97, 995-1012 (2008).
62. Wulff-Prez M, Glvez-Ruz MJ, Vicente J, Martn-Rodrguez A: Delaying lipid digestion through steric surfactant Pluronic F68: a novel in vitro approach. Food Res. Int. 43, 1629-1633 (2010).
63. Ren F, Jing Q, Cui J, Chen J, Shen Y: Self-Nanoemulsifying drug delivery system (SNEDDS) of anethole trithione by combined use of surfactants. J. Disp. Sci. Tech. 30, 664-670 (2009).
64. Yoo JH, Shanmugam S, Thapa P et al.: Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein. Arch. Pharm. Res. 33, 417-426 (2010).
65. Nielsen FS, Gibault E, Ljusberg-Wahren H, Arleth L, Pedersen JS, Müllertz A: Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds. J. Pharm. Sci. 96, 876-892 (2007). (Pubitemid 46657875)
66. Morais JM, Santos O, Delicato T, Rocha-Filho P: Characterization and evaluation of electrolyte influence on canola oil/water nano-emulsion. J. Disp. Sci. Tech. 27, 1009-1014 (2006). (Pubitemid 44151386)
67. Elnaggar YS, El-Massik MA, Abdallah OY: Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int. J. Pharm. 380, 133-141 (2009).
68. Nazzal S, Smalyukh II, Lavrentovich OD, Khan MA: Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation. Int. J. Pharm. 235, 247-265 (2002). (Pubitemid 34185455)
69. Taha EI, Samy AM, Kassem AA, Khan MA: Response surface methodology for the development of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Pharm. Dev. Technol. 10, 363-370 (2005).
70. Zidan AS, Sammour OA, Hammad MA, Megrab NA, Habib MJ, Khan MA: Quality by design: understanding the product variability of a self-nanoemulsified drug delivery system of cyclosporine A. J. Pharm. Sci. 96, 2409-2423 (2007).
71. Zhu S, Hong M, Liu C, Pei Y: Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation. Pharm. Dev. Technol. 14, 642-649 (2009).
72. Buyukozturk F, Benneyan JC, Carrier RL: Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. J. Control Release. 142, 22-30 (2010).
73. Fatouros DG, Deen GR, Arleth L et al.: Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering. Pharm. Res. 24, 1844-1853 (2007). (Pubitemid 47389238)
74. Fatouros DG, Mullertz A: In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability. Expert Opin. Drug Metab. Toxicol. 4, 65-76 (2008). (Pubitemid 351234101)
75. Koga K, Kawashima S, Murakami M: In vitro and in situ evidence for the contribution of labrasol and gelucire 44/14 on transport of cephalexin and cefoperazone by rat intestine. Eur. J. Pharm. Biopharm. 54, 311-318 (2002). (Pubitemid 35341831)
76. Rege BD, Kao J, Pollia J: Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur. J. Pharm. Sci. 16, 237-246 (2002).
77. Seeballuck F, Lawless E, Ashford MB: Stimulation of triglyceride-rich lipoprotein secretion by polysorbate 80: in vitro and in vivo correlation using Caco-2 cells and a cannulated rat intestinal lymphatic model. Pharm. Res. 21, 2320-2326 (2004). (Pubitemid 40568446)
78. Hugger ED, Audus KL, Borchardt RT: Effects of poly (ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers. J. Pharm. Sci. 91, 1980-1990 (2002).
79. Brüsewitz C, Schendler A, Funke A, Wagner T, Lipp R: Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds. Int. J. Pharm. 329, 173-181 (2007). (Pubitemid 44937529)
80. Subramanian R, Wasan KM: Effect of lipid excipients on in vitro pancreatic lipase activity. Drug Dev. Ind. Pharm. 29, 885-890 (2003). (Pubitemid 37203690)
81. Ren S, Park MJ, Kim A, Lee BJ: In vitro metabolic stability of moisture-sensitive rabeprazole in human liver microsomes and its modulation by pharmaceutical excipients. Arch. Pharm. Res. 31, 406-413 (2008).
82. Dixit RP, Nagarsenker MS: Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur. J. Pharm. Sci. 35, 183-192 (2008).
83. Bernkop-Schnurch A, Grabovac V: Polymeric efflux pump inhibitors in oral drug delivery. Am. J. Drug Deliv. 4, 263-272 (2006). (Pubitemid 46307156)
84. Cornaire G, Woodley J, Hermann P et al.: Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int. J. Pharm. 278, 119-131 (2004). (Pubitemid 38670443)
85. Sachs-Barrable K, Thamboo A, Lee SD, Wasan KM: Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells. J. Pharm. Pharm. Sci. 10, 319-331 (2007). (Pubitemid 350055592)
86. Lin Y, Shen Q, Katsumi H et al.: Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate in rats. Biol. Pharm. Bull. 30, 1301-1307 (2007). (Pubitemid 47037658)
87. Nielsen FS, Petersen KB, Müllertz A: Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur. J. Pharm. Biopharm. 69, 553-562 (2008).
88. Mustafa G, Khan ZI, Bansal T, Talegaonkar S: Preparation and characterization of oil in water nano-reservoir systems for improved oral delivery of atorvastatin. Curr. Nanosci. 5, 428-440 (2009).
89. Date AA, Nagarsenker MS: Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics. J. Pharm. Pharmacol. 59, 1583-1584 (2007).
90. Rao SV, Shao J: Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development. Int. J. Pharm. 362, 2-9 (2008).
91. Rao SV, Agarwal P, Shao J: Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: II. In vitro transport study. Int. J. Pharm. 362, 10-15 (2008).
92. Rao SV, Yajurvedi K, Shao J: Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs: III. In vivo oral absorption study. Int. J. Pharm. 362, 16-19 (2008).
93. Ruan J, Liu J, Zhu D et al.: Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique Int. J. Pharm. 386, 282-290 (2010).
94. El-Laithy HM: Self-nanoemulsifying drug delivery system for enhanced bioavailability and improved hepatoprotective activity of biphenyl dimethyl dicarboxylate. Curr. Drug Deliv. 5, 170-176 (2008).
95. Zhao Y, Wang C, Chow AH et al.: Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies. Int. J. Pharm. 383, 170-177 (2010).
96. Xi J, Chang Q, Chan CK et al.: Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS Pharm. Sci. Tech. 10, 172-182 (2009).
97. Singh SK, Verma PR, Razdan B: Glibenclamide-loaded self-nanoemulsifying drug delivery system: development and characterization. Drug Dev. Ind. Pharm. 36, 933-945 (2010).
98. Taha EI, Al-Saidan S, Samy AM, Khan MA: Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Int. J. Pharm. 285, 109-119 (2004). (Pubitemid 39361541)
99. Tarr BD, Yalkowsky SH: Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size. Pharm Res. 6(1), 40-43 (1989).
100. de Smidt PC, Campanero MA, Trocniz IF: Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility. Int. J. Pharm. 270, 109-118 (2004).
101. Yap SP, Yuen KH: Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations. Int. J. Pharm. 281, 67-78 (2004).
102. Izquierdo P, Wiechers JW, Escribano E et al.: A study on the influence of emulsion droplet size on the skin penetration of tetracaine. Skin Pharmacol. Physiol. 20, 263-270 (2007). (Pubitemid 47312681)
103. Cole ET, Cad D, Benameur H: Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Adv. Drug Deliv. Rev. 60, 747-775 (2008).
104. Taha EI, Al-Suwayeh SA, Anwer MK: Preparation, in vitro and in vivo evaluation of solid-state self-nanoemulsifying drug delivery system (SNEDDS) of vitamin A acetate. J. Drug Target. 17, 468-473 (2009).
105. Mahmoud EA, Bendas ER, Mohamed MI: Effect of formulation parameters on the preparation of superporous hydrogel self-nanoemulsifying drug delivery system (SNEDDS) of carvedilol. AAPS Pharm. Sci. Tech. 11, 221-225 (2010).
106. Mahmoud EA, Bendas ER, Mohamed MI: Preparation and evaluation of self-nanoemulsifying tablets of carvedilol. AAPS Pharm. Sci. Tech. 10, 183-192 (2009).
107. Wang Z, Sun J, Wang Y et al.: Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int. J. Pharm. 383, 1-6 (2010).
108. Abdalla A, Mader K: Preparation and characterization of a self-emulsifying pellet formulation. Eur. J. Pharm. Biopharm. 66, 220-226 (2007). (Pubitemid 46654779)
109. Tuleu C, Newton M, Rose J et al.: Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of Progesterone. J. Pharm. Sci. 93, 1495-1502 (2004). (Pubitemid 38725021)
110. Corveleyn S, Remon JP: Formulation of a lyophilized dry emulsion tablet for the delivery of poorly soluble drugs. Int. J. Pharm.166, 65-74 (1998). (Pubitemid 28239740)
111. Yi T, Wan J, Xu H, Yang X: A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur. J. Pharm. Biopharm. 70, 439-444 (2008).
112. Patil P, Paradkar A: Porous polystyrene beads as carriers for self-emulsifying system containing loratadine. AAPS Pharm. Sci. Tech. 7(1), E28 (2006).
113. Patil PR, Biradar SV, Paradkar AR: Extended release felodipine self-nanoemulsifying system. AAPS Pharm. Sci. Tech. 10(2), 515-523 (2009).
114. Nazzal S, Khan MA: Controlled release of a self-emulsifying formulation from a tablet dosage form: Stability assessment and optimization of some processing parameters. Int. J. Pharm. 315, 110-121 (2006) (Pubitemid 43674113)